News

Agrospheres Seeks EPA Approval For Inert Ingredient

AgroSpheres, Inc. progresses toward a key milestone in reducing pesticide impact in the environment. The submission of AgroSpheres™ Inert ingredient to the US Environmental Protection Agency (EPA) for use in agriculture inputs will further the company’s objective to make biopesticides more effective and reduce the rates of synthetic pesticide application. When approved, this technology will power a suite of environmentally-friendly crop health products for organic and conventional farming.

“The EPA submission marks our first major milestone towards the commercial establishment of our biorational portfolio which will bring sustainable products to our farmers and sustainable returns to our shareholders,” said Payam Pourtaheri, AgroSpheres’ CoFounder and CEO.

AgroSpheres™ Inert is a non-GM, fermentation-derived technology that will enhance biorational products. By replacing conventional inert ingredients like solvents and microplastics, this new technology will create an effective, biobased and biodegradable product line for growers.

“With this initial EPA submission, we are on track to deliver the first organic, inert technology that can transform the performance of both biological and synthetic pesticides,” said AgroSpheres’ CoFounder and CTO Ameer Shakeel. “Growers and investors can be confident we’re producing this ingredient in a controlled, zero-waste and proprietary bioprocess.”

“The AgroSpheres inert technology is both simple and elegant”, said Jerry Hjelle, Ph.D., AgroSpheres Scientific Advisor. “It is produced from a well-understood microbe with an established safety history. It enables a sustained release of organic, biological and conventional pesticides, creating the opportunity to reduce global pesticide use. The non-viable inert ingredient degrades in soil just like any other soil microorganism. This innovative approach to protecting organic and conventional foods and feeds has great potential.”

AgroSpheres developed the Inert technology to power eco-friendly ag product performance and significantly reduce chemical usage. The company is engaging leading global commercial partners that will enable broad access to reliable and novel biorational products. AgroSpheres™ Inert technology will empower crop health products that move us closer to realizing the company’s vision of a future built by nature’s technologies.

Recent News

11/21/2024

TearSolutions, Inc. Secures $3M Series B Funding

TearSolutions, Inc., a privately held biotech company developing potentially disruptive therapies for the treatment of ocular surface related diseases, today announced the successful closure of a $3M Series B round designed to accelerate its development programs for rare corneal diseases at both pre-clinical and clinical stages. “This round of financing is significant for several reasons,

11/21/2024

ReAlta Life Sciences Announces Appointment of Distinguished Biopharmaceutical Leader Lewis T. “Rusty” Williams, M.D., Ph.D. as Chairman of the Board

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, announced the appointment of Lewis T. “Rusty” Williams, M.D., Ph.D. as Chairman of its Board of Directors, effective immediately. Edward A. “Buzz” Heidt Jr., who has served

11/13/2024

VIPC Awards Regional Innovation Ecosystem Grant to Verge to Accelerate the Growing Innovation Economy Throughout Roanoke and The New River Valley

The Virginia Innovation Partnership Corporation (VIPC) announced that Roanoke and Blacksburg, Virginia-based Verge has been awarded a Regional Innovation Fund (RIF) grant for $200,000. Verge is the region’s front door for innovators, founders, and funders to work together and to provide a growing roster of companies – both startups and established – with resources to